Communication Improvement Feedback for Cancer Care
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to improve communication between healthcare providers and patients with serious illnesses, such as advanced cancer. Researchers will test whether feedback about communication can help doctors better understand and meet patient needs. The study includes two groups: one will receive feedback, while the other will continue with usual care. Patients at Duke Health may be suitable candidates for this trial. As an unphased trial, this study offers a unique opportunity to enhance patient-doctor communication, potentially improving care for future patients.
Do I need to stop taking my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this communication feedback method is safe for cancer care?
Research has shown that using feedback to improve communication in cancer care is generally well-received. One study found that feedback on doctor-patient interactions can benefit cancer care teams, indicating the approach is safe for patients. Another review examined various feedback methods in healthcare and identified safe practices.
In simpler terms, providing feedback to enhance doctor-patient conversations does not appear harmful. Instead, it can improve communication, which is crucial for patient care. No evidence suggests serious side effects or risks from this type of feedback.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it focuses on enhancing communication in cancer care, which is a key aspect often overlooked in traditional treatment plans. Unlike standard treatments that primarily target the physical aspects of cancer, this approach provides feedback to healthcare providers about their communication frequency and quality with patients. The aim is to improve patient-provider interactions, potentially leading to better patient satisfaction and outcomes. This trial is groundbreaking as it seeks to address the emotional and informational needs of cancer patients, which can be as crucial to recovery as the medical treatments themselves.
What evidence suggests that this feedback is effective for improving communication in cancer care?
Research has shown that providing feedback to healthcare providers about their communication with cancer patients can enhance the care process. In this trial, some participants will be in the intervention arm, where healthcare providers receive feedback on the frequency and quality of their communication. Studies have found that when doctors receive insights into their communication skills, they often improve in discussing important topics with patients. This improvement can lead to clearer conversations, which are crucial in cancer care. However, while communication improvements have been observed, the direct effect on patient health outcomes remains less clear. Better communication can help patients feel more understood and involved in their care decisions.678910
Are You a Good Fit for This Trial?
This trial is open to patients within the Duke Health system who are dealing with advanced serious illnesses such as cancer, heart failure, chronic obstructive pulmonary disease (COPD), or dementia. There are no specific exclusion criteria mentioned, so it appears to be quite inclusive.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Feedback to provider regarding frequency and quality of communication
Control
Usual care without additional interventions
Follow-up
Participants are monitored for frequency and timing of goals of care communication
What Are the Treatments Tested in This Trial?
Interventions
- Feedback
Find a Clinic Near You
Who Is Running the Clinical Trial?
Duke University
Lead Sponsor